Clinical Impact of Glucose Levels on Patient Outcome after Transcatheter Aortic Valve Replacement
Diabetic status is a predictor of short-term outcomes following TAVR. Thus, these screening parameters should be included in risk assessment tools for TAVR candidates.
Authors
- Gal Sella (ORCID: https://orcid.org/0000-0003-0383-6471)
- Yazan Hamdan
- Alena Kirzhner (ORCID: https://orcid.org/0000-0003-0457-432X)
- Omar Ayyad
- Haitham Abu Khadija (ORCID: https://orcid.org/0000-0002-2336-3125)
- Gera Gandelman
- Tal Schiller (ORCID: https://orcid.org/0000-0002-8378-2903)
- George Casella (ORCID: https://orcid.org/0000-0001-8154-8278)
- Alex Blatt
- Mohammad Alnees (ORCID: https://orcid.org/0000-0002-5577-8499)
- Yazid Kashquosh
- Mahdi Awwad
- Nadin Kakoush
Institutions
- Harvard University (US)
- Hebrew University of Jerusalem (IL)
- Kaplan Medical Center (IL)
Publication Details
- Journal
- Reviews in Cardiovascular Medicine
- Published
- 2025-02-21
- DOI
- https://doi.org/10.31083/rcm25336
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39